Filing Details
- Accession Number:
- 0001178913-22-001072
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2022-03-14 16:20:11
- Reporting Period:
- 2022-03-11
- Accepted Time:
- 2022-03-14 16:20:11
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1534248 | Chemomab Therapeutics Ltd. | CMMB | Pharmaceutical Preparations (2834) | 813676773 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1793602 | Nissim Darvish | C/O Chemomab Therapeutics Ltd. Kiryat Atidim, Building 7 Tel Aviv L3 6158002 | Yes | No | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| American Depositary Shares | Acquisiton | 2022-03-11 | 1,200 | $4.28 | 1,200 | No | 4 | P | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | P | Direct |
Reported Derivative Transactions
| Sec. Name | Sec. Type | Acquisiton - Disposition | Date | Amount | Price | Amount - 2 | Price - 2 |
|---|---|---|---|---|---|---|---|
| American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2022-03-07 | 6,820 | $0.00 | 6,820 | $3.53 |
| American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2021-04-19 | 11,884 | $0.00 | 11,884 | $27.26 |
| American Depositary Shares | Option to Purchase American Depositary Shares | Acquisiton | 2021-03-16 | 10,123 | $0.00 | 10,123 | $0.80 |
| Remaning Holdings | Exercise Date | Expiration Date | Equity Swap Involved | Transaction Form Type | Transaction Code | Nature of Ownership |
|---|---|---|---|---|---|---|
| 6,820 | 2032-03-07 | No | 4 | A | Direct | |
| 11,884 | 2031-04-19 | No | 4 | A | Direct | |
| 10,123 | 2026-10-27 | No | 4 | A | Direct |
Footnotes
- Each American Depositary Share (ADS) represents twenty (20) ordinary shares, no par value, of the Issuer.
- The ADSs are held of record directly by the Ashdanit Medical Ltd. (the "IRA"), which is self-managed by the Reporting Person. The Reporting Person is the sole ultimate beneficiary of the IRA and may be deemed to have sole voting and dispositive power with respect to the ADSs held by IRA.
- No transaction has been effected by the Reporting Person with respect to these securities, and they are being included in this Form 4 for informational purposes only.
- These options vest and become exercisable in their entirety on March 16, 2023, subject to the Reporting Person's continued service.
- These options vest and become exercisable in equal monthly installments over a 36 month period commencing on March 16, 2021, subject to the Reporting Person's continued service.
- The options reported in this row have all vested and are exercisable as of the date hereof, subject to the Reporting Person's continued service.
Billionaire Hedge Funds
